Amedalin
Group of stereoisomers
- None
- 3-Methyl-3-[3-(methylamino)propyl]-1-phenyl-1,3-dihydro-2H-indol-2-one
- 22136-26-1 Y
22232-73-1 (HCl)
- 31075
- 28832 Y
- 2OWK6X9N16
- D02891 N
- ChEMBL2110769 N
- Interactive image
- CC1(C2=CC=CC=C2N(C1=O)C3=CC=CC=C3)CCCNC
InChI
- InChI=1S/C19H22N2O/c1-19(13-8-14-20-2)16-11-6-7-12-17(16)21(18(19)22)15-9-4-3-5-10-15/h3-7,9-12,20H,8,13-14H2,1-2H3 Y
- Key:HBGWAZBZXJBYQD-UHFFFAOYSA-N Y
Amedalin (UK-3540-1) is an antidepressant which was synthesized in the early 1970s but was never marketed.[1][2] It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.[2][3]
See also
References
- ^ Triggle DJ (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 978-0-412-46630-4.
- ^ a b Cañas-Rodriguez A, Leeming PR (July 1972). "N-Phenyl-2-indolinones and N-phenylindolines. A new class of antidepressant agents". Journal of Medicinal Chemistry. 15 (7): 762–70. doi:10.1021/jm00277a017. PMID 5043876.
- ^ Koe BK (December 1976). "Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain". Journal of Pharmacology and Experimental Therapeutics. 199 (3): 649–661. PMID 994022.
- v
- t
- e
Specific reuptake inhibitors and/or receptor modulators | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Miscellaneous | |
---|---|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This article about an amine is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e